SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people-Reference-Cited by-同舟云学术

SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people

Published:2022-02 Issue:5 Volume:38 Page:110336
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Narowski Tara M.^ORCID,Raphel Kristin^ORCID,Adams Lily E.^ORCID,Huang Jenny,Vielot Nadja A.^ORCID,Jadi Ramesh^ORCID,de Silva Aravinda M.,Baric Ralph S.,Lafleur John E.,Premkumar Lakshmanane^ORCID

Funder

National Cancer Institute

National Institute of Allergy and Infectious Diseases

University of North Carolina at Chapel Hill

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference83 articles.

1. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants;Abu-Raddad;N. Engl. J. Med.,2021

2. Mutational analysis of SARS-CoV-2 ORF8 during six months of COVID-19 pandemic;Alkhansa;Gene Rep.,2021

3. Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination;Alter;Res. Square,2021

4. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection;Anderson;Cell,2021

5. SARS-CoV-2 vaccines: lights and shadows;Angeli;Eur. J. Intern. Med.,2021

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between circulating T follicular helper cell levels after infection and a decreased risk of COVID-19 re-infection;Virologica Sinica;2024-08

2. Formulation Development of a COVID-19 Recombinant Spike Protein-Based Vaccine;Vaccines;2024-07-23

3. Which test results to believe? Comparison of different ELISA kits for detection of SARS-CoV-2-neutralizing antibody among COVID-vaccinated individuals;Medical Journal Armed Forces India;2024-07

4. COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort;Science Advances;2024-06-14

5. Analysis of the Risk of COVID-19 in the Post-Vaccination Period Based on the Results of a Multicenter Study — a Survey of Medical Workers;Annals of the Russian academy of medical sciences;2024-02-29